12.07.2015 Views

Ana Paula Dias Ribeiro - Faculdade de Odontologia - Unesp

Ana Paula Dias Ribeiro - Faculdade de Odontologia - Unesp

Ana Paula Dias Ribeiro - Faculdade de Odontologia - Unesp

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

infection, parotitis and staphylococcal mucositis [2]. There is also scientific evi<strong>de</strong>ncethat the oral cavity can be the source of the staphylococci responsible for infection atdistant sites, such as aspiration pneumonia, endocarditis, acute septic arthritis andchronic lung diseases [3].As the oral cavity can be an important reservoir of this opportunistic pathogen,much effort has been ma<strong>de</strong> in or<strong>de</strong>r to promote the <strong>de</strong>colonization of Staphylococcuscarriers [4]. However, the strategies to eliminate the S. aureus strains have beenchallenged with the <strong>de</strong>velopment of antibiotic-resistant microorganisms, such as themethicillin-resistant S. aureus (MRSA). Strains of MRSA were first <strong>de</strong>tected in 1961and these pathogens are currently prevalent worldwi<strong>de</strong> [5]. MRSA has become amajor problem in nososcomial infections as it is responsible for significantly highermorbidity and mortality and increased healthcare costs [6]. It is known that thecolonization prece<strong>de</strong>s the systemic infection and therefore <strong>de</strong>colonization may reducethe risk of MRSA infection in individual carriers and prevent cross-infection to otherpatients or healthcare workers. Intranasal mupirocin, daily chlorhexidine body wash,antibiotics such as rifampin and doxycline, oral hygiene procedures, use of <strong>de</strong>nturecleansingagents and <strong>de</strong>nture sterilization methods have been proposed to preventcolonization by MRSA and methicillin-susceptible S. aureus (MSSA) [6,7]. However,a systematic review conclu<strong>de</strong>d that there is insufficient evi<strong>de</strong>nce to support the use ofany topical or systemic antimicrobial therapy for eradicating MRSA [8].The photodynamic therapy (PDT) has emerged in the clinical field as apotential alternative to antibiotics for inactivating resistant microorganisms using anon-toxic light-sensitive compound (known as photosensitizer - PS), visible light andoxygen. Briefly, activation of the PS by a visible light that matches its photophysicalproperties generates reactive oxygen species (ROS) like free radicals by electron orhydrogen transfer (type I reaction) or reactive singlet oxygen by direct energy transferto oxygen (type II reaction) [9]. Photodynamic inactivation of microorganisms hasadvantages, such as the local application of PS and light, which limits the action ofROS and avoids systemic effects on normal bacterial flora [10]. In addition, unlikeantibiotics, which have a single target in the microbial cell, the reactive speciesgenerated by the photodynamic reaction have a multifunctional nature and candamage multiple cellular structures, reducing the chances of <strong>de</strong>velopment of PDTresistantstrains [11]. Dovigo et al. [12] observed that fluconazole-resistant C. albicansand C. glabrata strains were sensitivity to PDT, although they were less susceptible

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!